<DOC>
	<DOC>NCT01524796</DOC>
	<brief_summary>Observational study to assess the effectiveness and use of pregabalin (Lyrica) in the treatment of patients with peripheral neuropathic pain in real-life daily clinical practice.</brief_summary>
	<brief_title>NEP-TUNE: Neuropathic Pain - Treatment With Pregabalin Under Real-life Conditions in Denmark</brief_title>
	<detailed_description>General practitioners and specialists participate in the study. When a subject, independently of the study and before consideration for observation in the study has been prescribed pregabalin for treatment of peripheral NeP, the subject can (before first dose of pregabalin is taken) be included in the observational program.</detailed_description>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Subjects aged 18 years or over. Subjects diagnosed with peripheral neuropathic pain. Subjects that independently of the study and before consideration for observation in the study have been prescribed pregabalin for treatment of peripheral neuropathic pain either. 1. for the first time ('first prescription patients') or 2. that have not used pregabalin within the previous 6 months but are prescribed pregabalin again ('retreatment patients') Subjects that haven't taken the first dose of the prescribed pregabalin yet. Subjects not consenting to participate. Subjects that at study inclusion (baseline) are on treatment with pregabalin for generalized anxiety or epilepsy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Real-life</keyword>
	<keyword>non-interventional</keyword>
	<keyword>observational</keyword>
	<keyword>peripheral neuropathic pain</keyword>
	<keyword>Lyrica</keyword>
	<keyword>pregabalin</keyword>
</DOC>